AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
4 other identifiers
interventional
107
1 country
2
Brief Summary
There is an epidemic of thyroid cancer that is harmful to patients and the medical system. The study hypothesizes that the use of an electronic conversation aid during clinical visits can help patients and clinicians collaborate. The study aims to update a conversation aid prototype that was developed to support shared decision making in the diagnosis of thyroid cancer and conduct a pilot clinical trial to evaluate the feasibility of conducting a larger efficacy study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedStudy Start
First participant enrolled
February 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedResults Posted
Study results publicly available
November 10, 2025
CompletedNovember 10, 2025
December 1, 2024
2.6 years
July 6, 2020
August 28, 2025
October 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of Eligible Patients for Feasibility
Proportion of participants that are eligible relative to total trial referrals.To measure the proportion of eligible patients after review of upcoming clinical visits, enrollment and refusal reasons, ability to randomize patients and tolerability by patients and clinicians of the required assessments (time to complete assessments and obtain complete assessment at 6 months of follow up).
at 6 months of follow up
Secondary Outcomes (16)
Patient's Acceptance to Participate in the Study
first visit
Adequate Randomization
initial clinical visit
Completeness of Baseline Survey (Patients)
baseline
Patient Survey (6 Months)
6 months
Clinician Baseline Survey
baseline
- +11 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALCounseling using the electronic conversation aid
Control Group
ACTIVE COMPARATORRoutine counseling only
Interventions
Patients receive counseling about thyroid biopsy with the use of the conversation aid.
Patients receive counseling by routine care without the use of the conversation aid
Eligibility Criteria
You may qualify if:
- Adults \>18 years old presenting for evaluation of a thyroid nodule
You may not qualify if:
- Patients with hyperthyroidism
- Patients with previous biopsy of the nodule of interest
- Pregnant patients
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- National Cancer Institute (NCI)collaborator
Study Sites (2)
University of Florida
Gainesville, Florida, 32610, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Naykky Singh Ospina
- Organization
- University of Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Naykky Singh Ospina
University of Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2020
First Posted
July 9, 2020
Study Start
February 20, 2022
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
November 10, 2025
Results First Posted
November 10, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share